MEROPENEM

Meropenem

Composition: each vial contains:

active substance: meropenem – 500 mg.

Therapeutic indications

Meropenem is indicated for the treatment of the following infections in adults and children over 3 months of age:

  •  pneumonia, including community acquired pneumonia and nosocomial pneumonia;

  •  broncho-pulmonary infections in cystic fibrosis;

  •  complicated urinary tract infections;

  •  complicated intra-abdominal infections;

  •  intra- and post-partum infections;

  •  complicated skin and soft tissue infections;

  •  acute bacterial meningitis.

Meropenem may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

	АТС code
	J01DH02
	Pharmaceutical form
	powder for solution for intravenous injection 1000 mg
	Storage conditions
	Store in protected from light place at temperature below 25°C.